Daily non-political popular news in brief.
Newly identified biomarker detects and regulates spread of brain tumors
11-10-2006 · EurekAlert!Researchers have identified a novel biomarker for brain tumors and have uncovered a potential role the marker may play when the tumor spreads or comes back after treatment. The biomarker, a protein known as "soluble attractin," is normally absent in the central nervous system and is undetectable in cerebral spinal fluid unless malignant astrocytomas are present in the CNS. This newfound ability to identify biomarkers for malignant astrocytomas means physicians will have a minimally invasive method to track the success of treatments.
Read more »
Keywords: newly, identified, biomarker, detects, regulates, spread, brain, tumors, detect, regulate, tumor
« Previous | Next »
Similar news on "Newly identified biomarker detects and regulates spread of brain tumors":
- MIT IDs link between brain tumor proteins
07-19-2007 · EurekAlert!
MIT researchers have identified a critical link between two proteins found in brain tumors, a discovery that could eventually help treat a form of brain cancer that kills 99 percent of patients.
Similar news · Read more »
- Imaging neural progenitor cells in the living human brain
11-08-2007 · EurekAlert!
For the first time, investigators have identified a way to detect neural progenitor cells, which can develop into neurons and other nervous system cells, in the living human brain using a type of imaging called magnetic resonance spectroscopy. The finding, supported by the National Institutes of Health, may lead to improved diagnosis and treatment for depression, Parkinson's disease, brain tumors, and a host of other disorders.
Similar news · Read more »
- Brain tumors coax important support from nearby immune system cells
04-11-2007 · EurekAlert!
Developing brain tumors can coax assistance from nearby cells known as microglia, according to a new study from scientists at Washington University School of Medicine in St. Louis. The researchers have identified one protein made by microglia that helps accelerate tumor growth and are looking for others.
Similar news · Read more »
- 2 microRNAs promote spread of tumor cells
01-28-2008 · EurekAlert!
Scientists at The Wistar Institute and their colleagues have identified two microRNAs that promote tumors' deadly spread. One of the miRNAs may provide an early warning of metastatic breast cancer and the need for aggressive treatment. In a study to be published Feb. 1 in Nature Cell Biology that is available online, the researchers describe how two miRNAs transformed non-invasive human breast cancer cells into cells that rapidly metastasized in cell cultures and mice.
Similar news · Read more »
- Team of scientists develops non-invasive method to track nerve-cell development in live human brain
11-08-2007 · EurekAlert!
A team of scientists including researchers at Cold Spring Harbor Laboratory have identified and validated the first biomarker that permits neural stem and progenitor cells to be tracked, non-invasively, in the brains of living human subjects. This important advance could lead to significantly better diagnosis and monitoring of brain tumors and a range of serious neurological and psychiatric disorders.
Similar news · Read more »
- Three new lung tumor subtypes identified in DNA profiling study
10-30-2006 · EurekAlert!
A new study has identified three subtypes of non-small-cell lung cancer tumors, a finding that may provide valuable clinical information about patient survival in early- or late-stage disease, how likely the cancer is to spread and whether the tumor will prove resistant to chemotherapy.
Similar news · Read more »
- Analysis of breast and colon cancer genes finds many areas of differences between tumors
10-11-2007 · EurekAlert!
Researchers from University Hospitals Ireland Cancer Center and Case Western Reserve University School of Medicine are part of a new national study that has analyzed more than 18,000 genes, including 5,000 previously unmapped genes, from breast and colorectal tumors. The study shows a great number of genetic differences between breast and colon cancer tumors, leading the researchers to conclude that new drugs must be developed that can hit these newly identified genetic targets in a manner specific to each different individual's tumor.
Similar news · Read more »
- Novel regulation of the common tumor suppressor PTEN
01-11-2007 · EurekAlert!
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon and brain. Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the Jan. 12 issue of Cell.
Similar news · Read more »
- Drug combination might offer hope for patients deadly brain tumors
10-18-2007 · EurekAlert!
Brain cancer patients with the poorest prognosis -- those with a type of deadly tumor known as glioblastoma multiforme -- may survive longer with a drug that chokes off a tumor's blood supply.
Similar news · Read more »
- AVN944 inhibits IMPDH and induces apoptosis-related biomarkers in patients with hematologic cancers
12-11-2006 · EurekAlert!
IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
Similar news · Read more »
